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ABSTRACT
A subtelomeric region, 4q35.2, is implicated in
facioscapulohumeral muscular dystrophy (FSHD),
a dominant disease thought to involve local patho-
genic changes in chromatin. FSHD patients have too
few copies of a tandem 3.3-kb repeat (D4Z4)
at 4q35.2. No phenotype is associated with having
few copies of an almost identical repeat at 10q26.3.
Standard expression analyses have not given
definitive answers as to the genes involved. To
investigate the pathogenic effects of short D4Z4
arrays on gene expression in the very gene-poor
4q35.2 and to find chromatin landmarks there
for transcription control, unannotated genes
and chromatin structure, we mapped DNaseI-
hypersensitive (DH) sites in FSHD and control
myoblasts. Using custom tiling arrays (DNase-
chip), we found unexpectedly many DH sites in the
two large gene deserts in this 4-Mb region. One site
was seen preferentially in FSHD myoblasts. Several
others were mapped >0.7Mb from genes known
to be active in the muscle lineage and were
also observed in cultured fibroblasts, but not in
lymphoid, myeloid or hepatic cells. Their selective
occurrence in cells derived from mesoderm
suggests functionality. Our findings indicate that
the gene desert regions of 4q35.2 may have func-
tional significance, possibly also to FSHD, despite
their paucity of known genes.
INTRODUCTION
One of the best cell culture models for mammalian diﬀer-
entiation is the induction of myotube formation from
cultured myoblasts. However, only one high-resolution
study of chromatin has been reported for human
myoblasts, namely, analysis of histone H4 hyperacety-
lation on a single fetal myoblast cell strain using a com-
mercial SNP tiling array (1). High-resolution analyses of
other human cell types for chromatin epigenetics and
annotation-neutral searches for transcripts are revealing
evidence for many new diﬀerentiation-associated genes,
alternative transcription start sites and transcription
control elements within genes or located distant from
them (2–6).
We have begun analysis of chromatin structure in
myoblasts by focusing on 4q35.2, the subtelomeric chro-
mosomal region that contains a muscular dystrophy-
linked repeat array, D4Z4. The relationship of D4Z4 to
pathogenic gene dysregulation in facioscapulohumeral
muscular dystrophy (FSHD) is still enigmatic. FSHD is
the only known disease caused by having additional few
copies of a long, tandemly repeated sequence (7). More
than 95% of FSHD patients have only 1–10 copies of this
3.3-kb repeat unit on one allelic 4q35.2 (Figure 1A), while
unaﬀected individuals have 11–100 copies on both 4q35.2
alleles. This progressive and painful disease is usually
diagnosed in the teens. It is initially conﬁned to certain
groups of skeletal muscles and has no eﬃcacious treat-
ment. An extremely low copy number of 4q35 D4Z4
repeats (1–3) often correlates with an earlier onset and
more severe disease but no FSHD-linked array has been
found to have zero copies of the repeat unit (7).
Several ﬁndings implicate the involvement in FSHD of
sequences in cis to a short D4Z4 array on 4q35.2. A short
D4Z4 array by itself does not cause FSHD because almost
identical arrays on 10q26.3 have no phenotypic eﬀect even
when they are equally short (7). This 4q-dependence of
pathogenicity is found despite 98% homology between
4q and 10q within D4Z4 and >95% homology centromere
proximally for 42 kb and distally for  15–25kb up to the
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base sequence variations distinguish canonical 4q35.2
D4Z4 repeat units from those of 10q26.3 (7). A short
canonical 4q35-type D4Z4 array on 10q26.3 does not
lead to FSHD while a short 10q26.3-type array on
4q35.2 does (9). Therefore, the chromosomal position of
the 4q35.2 D4Z4 array links it to FSHD. Nonetheless,
there is only controversial or incomplete evidence for
functional linkage of FSHD to a 4q35-speciﬁc gene
despite many expression microarray and real-time PCR
(RT-PCR) studies (10–14).
We and others have focused attention on the proximal
side of the D4Z4 array in subtelomeric 4q because no
genes have been found in the short partially sequenced
subregion distal to the array (7). Moreover, the short
D4Z4-distal region shares high homology between 4q
and 10q (15). Sequences at 4q35.2, which may be
implicated in the disease, should be >78kb proximal to
D4Z4 because naturally occurring deletions of sequences
within this  78-kb proximal region (Figure 1) do not
impact the phenotype of FSHD patients carrying a short
D4Z4 array in cis (16). The furthest proximal sequence
that is considered a disease candidate gene is SLC25A4
(ANT1), which is located on 4q35.1  5Mb proximal to
D4Z4. Disease-linked SLC25A4 overexpression was seen
in some studies (17,18) but not others (11–13).
We proposed that there is a long-distance interac-
tion between a short D4Z4 array and some unidentiﬁed
proximal gene present on subtelomeric 4q, but not on 10q,
that results in FSHD-speciﬁc transcription dysregulation
(19,20). Long-range control of disease-related gene
expression in humans can occur by looping interactions
of  1Mb and even longer interactions may occur (21,22).
The hypothesized long-range pathogenic interaction of
short D4Z4 arrays and other 4q sequences in cis should
involve a ‘molecular ruler’ that recognizes diﬀerences in
sizes of D4Z4 arrays slightly above or below a near thresh-
old of 33kb (10 3.3-kb repeat units). Because it is the most
likely region for the postulated cis-interactions, the 4Mb
of 4q35.2 with the addition of the SLC25A4 gene at
4q35.1 were the focus of the present study of chromatin
in FSHD and control myoblasts. About 80% of 4q35.2 is
devoid of known genes, including no reported micro RNA
(miRNA) genes. Approximately 25% of the genome
consists of gene-poor regions >500kb termed gene
deserts (23). Studying 4q35.2, which is mostly gene
desert, should enhance our understanding of the underly-
ing chromatin structure of the human genome as well as
the molecular genetics of FSHD.
Using FSHD and control myoblast cell strains, we
mapped DNaseI-hypersensitive (DH) sites at high resolu-
tion. DH sites are associated with nucleosome-free
chromatin and various gene regulatory elements (24).
Approximately 30% of them are in promoters of genes
that are active or poised for activity (6,24). Crawford
and colleagues (2,6,25) developed two speciﬁc high-
throughput methods to identify large numbers of DH
sites at once, using tiled arrays (DNase-chip) or high-
throughput sequencing (DNase-seq). We analyzed
myoblasts with DNase-chip, which employs custom
tiling arrays and is ideally suited for analysis of targeted
regions of the genome. Because DNase-chip and
Figure 1. Schematic comparison of the subtelomeric region of 4q containing FSHD-linked D4Z4 arrays (A) and that of 10q, whose D4Z4 arrays are
always non-pathogenic (B). Near their distal end, the 4q35.2 and 10q26.3 regions contain  98% identical 4q and 10q D4Z4 arrays (8) and other
highly homologous sequences outlined in pink. DUX4, within each D4Z4 repeat unit (pink triangle), has no polyA signal except for the most distal
copy, which borrows a poly(A) signal from sequences distal to the array (34,35). DUX4 is weakly expressed, has mostly truncated transcripts, is
highly polymorphic in number of copies of the repeat (1–100) and shows no more expression from longer than shorter arrays (34,35). Therefore, it
was counted as a single gene for the tally of RefSeq genes. DUX4C (grey font) is a predicted gene, not a RefSeq gene.
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levels of sensitivity (92%) and speciﬁcity (94%) (6), we
could also compare data from DNase-chip on FSHD
and control myoblasts and with DNase-seq mapping of
DH sites from other cells types.
MATERIALS AND METHODS
Cell culture
Myoblast cell strains from FSHD patients (F1, 2 and 3;
28-year-old male, 18-year-old female and 14-year female,
respectively) were derived from moderately aﬀected,
deltoid or quadriceps biopsies of FSHD patients. Their
disease-linked D4Z4 arrays had three, three and two
3.3-kb 3U, respectively. The control myoblasts (C1,
31-year female, 31 years; C2 and C3, two diﬀerent
batches of myoblasts from a 27-year-old male) were from
similarbiopsiesofunaﬀectedindividuals.Theseindividuals
were unrelated except for the 27-year-old unaﬀected male,
who was the brother of patient F1. Duly signed patient
consent forms were obtained that had been approved by
the Institutional Review Boards of Tulane Health Science
Center and the University of Mississippi Medical Center in
Jackson. Myoblasts were propagated and checked by
immunocytochemistry for desmin (20), a marker for
muscle cells; >90% of the cells in the batches used for
these experiments were desmin-positive.
DNA and RNA isolation
Total RNA was extracted with TRIzol reagent
(Invitrogen) and treated with DNaseI (Turbo DNA-free,
Ambion). cDNA was synthesized (SuperscriptIII,
Invitrogen) using random hexamer primers. Quantitative
real-time polymerase chain reaction (qRT-PCR) was per-
formed (SYBR Green Detection; iQ5, BioRad) with the
following parameters: 95 C, 30s; 63 C, 30s; 72 C, 30s for
45 cycles. For each sample analyzed, RT-minus controls
were included. For each primer-pair (Supplementary
Table S2), a standard curve with serial 10-fold dilutions
of genomic DNA and the melting curve of the product
were generated. The slopes of the standard curves were
 3.3±0.4 and the correlation coeﬃcients were >0.98.
The RNA level is represented as 1000 times the quantity
(in arbitrary units) relative to that for human hypo-
xanthine phosphoribosyltransferase (HPRT).
DNase-chip
DNase-chip was performed as previously described (25).
Brieﬂy, myoblasts from normal control and FSHD
patients were lysed with NP40 and nuclei were lightly
digested with optimal concentrations of DNaseI
(Roche). High-molecular weight DNase-treated DNA
was prepared, and DNase-digested ends were repaired
by T4 DNA polymerase (New England Biolabs).
Biotinylated linkers were ligated to the DNase ends and
the ligation product was sonicated to an average size of
300–700bp. DNase ends were captured on streptavidin
beads (Invitrogen), sheared ends were blunted with T4
DNA polymerase and repaired ends were ligated to a
second set of linkers. DNase-enriched material was
ampliﬁed by PCR, labeled and hybridized to custom
tiling arrays (NimbleGen). These tiling arrays contained
probes from across 4q35.2 [chromosome 4 (chr4):
187300001–191273063; all positions are relative to
hg18, UCSC Genome Browser] and the ANT1 locus
(chr4:186291392–186315418). Because there are many
repetitive sequences within these regions, we included
probe sets that overlapped moderately repeated sequences,
including probe sets from the 3.3-kb D4Z4 repeat, but not
highly repeated sequences (http://www.repeatmasker
.org/). All probes (average  30-nt overlap) were
designed using an isothermal probe selection strategy,
where probes were 45–75 nt in length and were size-
adjusted to give a Tm of 76 C. Due to the extremely
high GC content (73%) and repetitive nature of the
D4Z4 region, two additional sets of isothermal probes
were designed to have a Tm of 79 or 82 C. DNase-chip
data were analyzed as previously described (25,26). Data
were visualized in custom tracks of the UCSC Genome
Browser (http://genome.ucsc.edu/) or the Integrated
Genome Browser (http://www.aﬀymetrix.com/).
RESULTS
Gene deserts in 4q35.2
The terminal 3Mb of the q arm of chr4 in 4q35.2 has the
lowest gene density of all the autosomal q arms
(Supplementary Figure S1). Within 4q35.2, there are two
central gene deserts occupying 3.1Mb and separated by
three genes, ZFP42, TRIML1 and TRIML2 (Figure 2).
ZFP42 is a marker for pluripotent stem cells (27).
TRIML1/Triml1, which encodes a RING ﬁnger protein,
is expressed in preimplantation mouse embryos (28).
Similarly, the related provisional geneTRIML2 seems to
be very restricted in its expression (http://biogps.gnf.org).
Consistent with previous ﬁndings about the regions of low
gene density (29), the 4q35.2 gene desert regions consist
predominantly of low (G+C) isochores [IsoFinder (30)]
and have low concentrations of short interspersed repeats
(SINEs; Supplementary Figure S2).
DH sites in gene deserts in myoblasts
We mapped DH sites in vivo in three FSHD and three
normal-control myoblast cell cultures at 4q35.2 by
DNase-chip. The DH fraction (labeled with Cy5) and the
randomly sheared DNA (labeled with Cy3) were
cohybridized to custom tiling arrays. Our DH mapping
results indicated that 4q35.2 in myoblasts has three
chromatin domains diﬀering in the density of DH sites.
The most proximal (DHS domain 1, Figure 2) had the
highest density of DH sites seen at 4q35.2, in accord with
its higher gene content. However, DH sites in this domain
extended far into the adjacent gene desert. The distal
domain (DHS domain 3) contains several genes near its
telomeric end. Only one of these, FRG1, is expressed at a
substantial level in myoblasts or other tested cell types
(Table 1). Surprisingly, the DH sites observed in all
myoblast strains in this domain included sites
that extended 0.9Mb from FRG1 into the neighboring
Nucleic Acids Research, 2009,Vol.37, No. 22 7383gene desert. DHS domain 2, which is located in the middle
of 4q35.2, had a much lower density of DH sites, and none
was detected in more than two of the six myoblast cultures.
The only genes in this domain are ZFP42, TRIML1 and
TRIML2, which are associated with stem cells or early
embryogenesis, as mentioned earlier.
Three DH sites, DH8, -9 and -10, were located near the
boundary of DHS domains 1 and 2 and were situated
 0.4–0.5Mb proximal to ZFP42 and  0.75–0.9Mb
distal to FAT1, the nearest gene known to be expressed
in the muscle (Figure 2). These DH sites contain unique
DNA sequences and were of similar intensity in all FSHD
and control myoblast cell strains (Figures 2 and 3A).
Recently, DH sites were identiﬁed across the whole
genome from a number of human cell types by DNase-
seq. This is a similar strategy to DNase-chip but uses next-
generation sequencing (6). Even though DNase-seq and
DNase-chip rely on diﬀerent readout platforms, they
have been shown to be highly correlated. The DNase-
seq data have been generated as part of the ENCODE
project and made available on the UCSC Genome
Browser (http://genome.ucsc.edu/, Open Chromatin
track). DNase-seq data from K562 (myeloid leukemia
cell line), HepG2 (hepatocellular carcinoma cell line),
GM12878 (lymphoblastoid cells), HeLa S3 cells and
primary CD4
+ T-cells, revealed no appreciable DH
peak at the genomic positions of DH8, 9 or 10;
however, two skin ﬁbroblast cell strains did exhibit these
peaks [Figure 3A and data not shown; all but the CD4
+
data (6) are previously unpublished]. In some cell types,
 4kb distal to DH10, a DH site was observed that
overlapped a CCCTC-binding factor (CTCF) binding
site identiﬁed by chromatin immunoprecipitation (ChIP)
followed by next-generation sequencing (ChIP-seq) or
tiling array analysis (Figure 3A).
DH sites at FSHD candidate genes in myoblasts
Five genes in 4q35.2 (DUX4, DUX4C, FRG1, FRG2 and
TUBB4Q; Figure 4) and one at 4q35.1 (SLC25A4/ANT1)
have been considered as candidates for the 4q-speciﬁc
pathogenicity of short D4Z4 arrays (10,17,32,33,35,36).
Of these FSHD candidate genes, only FRG1 has easily
detectable expression at the RNA level (Table 1).
Overexpression of FRG2, FRG1 and SLC25A4 RNA in
FSHD versus control muscle was reported to be >60-,
>25- and  10-fold, respectively (10,17). In addition,
FSHD-associated elevation of protein levels was
detected for SLC25A4 (18). Among the FSHD candidate
genes on 4q35, DH sites were detected only at the
promoters of FRG1 and SLC25A and no signiﬁcant
Figure 2. DH sites at 4q35.2 in myoblast cell strains are present in gene deserts as well as in the vicinity of known genes. Green dots, unique DH
sites, seen in all six myoblast cultures; orange dot, DH272, seen preferentially in the three FSHD myoblast cell strains and grey dots, DH sites
overlapping STRs (70) and seen in all six myoblast cultures. DH site domains are indicated as described in the text. Blue boxes near the bottom of
the ﬁgure are regions of segmental duplications shared with various chromosomes; the 4q/10q segmental duplication is shown at the bottom of
the ﬁgure. SLC25A4 (ANT1), which is 5Mb proximal to D4Z4 and included in the probe set, is not indicated in this ﬁgure because it is located
on 4q35.1.
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FSHD and control myoblasts (Figure 4, inset and data not
shown). However, the biological signiﬁcance of DH signal
intensity is unknown and diﬀerent DH sites display a wide
range of openness (6). Moreover, by qRT-PCR, there was
not a signiﬁcant association of the relative concentration
of FRG1 or SLC25A4 RNA with disease status in
myoblasts. The relative steady-state RNA levels for
FSHD versus control myoblasts were 1.4 for FRG1 and
2.0 for ANT1 (P>0.5; assays of three FSHD versus three
control myoblast cell strains in duplicate).
The ability to detect DH sites at promoters of TUBB4Q,
DUX4C, FRG2 and DUX4 in the terminal 0.25Mb
of4q35.2 is complicated by this region containing many
segmental duplications (Figure 4). With the exception of
the 50-end of FRG1 (37), analysis of all known 4q-terminal
genes is diﬃcult by almost any experimental method
because of the near-absence of unique sequences. A
further complication is that some of the sequences cross-
hybridizing to this region of 4q35.2, especially within
D4Z4 itself, are contained within incompletely sequenced
regions of the genome, notably the short arms of the
acrocentric chromosomes (38,39). Consequently, while
there was suﬃcient probe coverage for TUBB4Q,
DUX4C and FRG2 regions on the array, there was no
coverage with unique probes.
Repeat-masked coverage for D4Z4, including its
internal DUX4 gene, consisted of only scattered probes.
DUX4 is the 1.6-kb homeobox-containing gene within
each 3.3-kb D4Z4 repeat unit. Given the poor coverage
with repeat-masking, we attempted to analyze the D4Z4
region by including probe sets that corresponded to these
repetitive segments. DH sites in D4Z4 might be detected if
all paralogs behaved similarly. However, the signal from
D4Z4 probes did not identify any DH sites in this subre-
gion (data not shown).
Other myoblast DH sites near genes in 4q35.2
Among the six genes in 4q35.2 at the proximal end
(Figure 2 and Table 1), DH sites in or near the
promoter region were observed for FAT1, a cadherin
gene involved in cell migration; CYP4V2, a cytochrome
P450 family member and FAM149A, a RefSeq gene of
unknown function encoding a hypothetical protein
(Figure 3B, Supplementary Figures S3 and S4). Multiple
DH sites in FAT1 introns were consistently seen in the
myoblasts cultures (Supplementary Figure S3). No
FSHD-associated diﬀerences were observed at any of
these DH sites. The adjacent gene MTNRIA, a melatonin
receptor gene, had a highly reproducible DH site within
the ﬁrst intron, but not at the 50-end (Supplementary
Figure S3). Accordingly, MTNRIA RNA was not detect-
able in FSHD or control skeletal muscle, as determined on
cDNA expression microarrays (11). No DH sites were
observed at two other proximal 4q35.2 genes, KLKB1
and F11, which encode proteins involved in blood coagu-
lation. One of the few described mRNAs from the
terminal 1Mb of 4q is AY956760 (590-kb proximal to
the D4Z4 array), the reported product of the heat shock
protein gene HSP90AA4P. No DH site was observed in its
Table 1. DH sites and Refseq genes in the 4q35.2 region










FAM149A Promoter Moderate Curated 3893 187307320 187330811 +
CYP4V2 First intron Moderate Curated 3852 187349667 187371611 +
KLKB1 None Little or no Curated 3807 187385665 187416619 +
F11 None Little or no Curated 3776 187424111 187447829 +
MTNR1A First intron Little or no Curated 3510 187713531 187691802  
FAT1 One in the promoter
and six in introns
Moderate Curated 3342 187881981 187745930  
ZFP42 None Little or no Curated 2060 189153918 189163193 +
TRIML2 None Little or no Provisional 1960 189263402 189249420  
TRIML1 None Little or no Provisional 1918 189297591 189305643 +
FRG1 Promoter Moderate Curated 102 191098967 191121353 +
TUBB4Q
c None Little or no Pseudogene 81 191143018 191140671  
DUX4C
d None None Predicted 43 191180814 191177249  
FRG2 None Little or no Provisional 38 191185406 191182516  
DUX4
e None Low Curated Inside D4Z4 191226073 191227684 +
aRelative RNA levels are based on gene expression array data from nine reconstructive surgery skeletal muscle samples [http://bioinfo.amc.uva
.nl/HTMseq/controller, (31)] and four skeletal muscle samples (http://biogps.gnf.org). All genes listed as having moderate expression in skeletal
muscle are expressed in a variety of tissues. ZFP42 and TRIML1 have very tissue speciﬁc and development-restricted expression, as described in the
text. TRIML2 has low expression in skeletal muscle.
bThe status of these gene is based on RefSeq data from National Center for Biotechnology Information (NCBI).
cTUBB4Q is considered to be a pseudogene based upon the sequence of its open reading frame and lack of transcripts (32).
dAlthough related to DUX4 and considered as an FSHD candidate gene (33), DUX4C is a predicted gene (http://www.genecards.org) not included in
RefSeq genes.
eNo data are available from microarray expression analyses for this gene due to the lack of speciﬁc probes. From RT-PCR, its expression level is low,
most transcripts are not full-length transcripts and most are not polyadenylated; moreover, transcripts were also found from other parts of the 3.3-kb
D4Z4 repeat unit outside of the 1.6-kb DUX4 region and include antisense transcripts (34).
Nucleic Acids Research, 2009,Vol.37, No. 22 7385vicinity in myoblasts or the other investigated cell types
(data not shown).
Tissue-speciﬁc patterning of DH sites along 4q35.2
We next compared the positions of DH sites along the
length of 4q35.2 between myoblasts and diverse cell
types. Many reproducible cell type-speciﬁc diﬀerences
were observed, including diﬀerences in DH sites in
gene deserts (Figure 5). Importantly, myoblast-speciﬁc
diﬀerences in DH sites at documented genes were seen
most prominently within the large FAT1 gene (Figure 5
and data not shown), which is subject to complicated alter-
native splicing and implicated in modulating cell contacts
(40) and repair of vascular smooth muscle injury (41). For
replicates of a given cell type, the positions and relative
signal intensities of DH sites were remarkably consistent,
even when the replicates were from diﬀerent individuals (as
for myoblasts and ﬁbroblasts). This indicates that genetic
polymorphisms are not responsible for the observed cell
type-speciﬁc diﬀerences. Myoblasts were most similar to
skin ﬁbroblasts in their distribution of DH sites along
subtelomeric 4q, although these two cell types did display
some diﬀerences (Figure 5). The muscle speciﬁcity of DH
sites in 4q35.2 was conﬁrmed in preliminary whole-genome
DNase-seq analysis of control myoblasts (Crawford, G.E.
and Ehrlich, M. et al., unpublished data).
Figure 3. DH sites in the proximal half of 4q35.2. (A) DH sites 8, 9 and 10 in the 1.3-Mb gene desert of 4q35.2 were seen in myoblasts and
ﬁbroblasts but not other cell types. DH sites in the middle of a gene desert are shown for FSHD and control myoblast cell strains and other cell
types. For myoblasts, the average data for DH peak height for three FSHD and three control myoblast cultures from DNase-chip are displayed.
Individual representative samples from DNase-seq are shown for a skin ﬁbroblast cell strain (GM05879), lymphoblastoid cell line (GM12878), K562
cells (myelogenous leukemia cell line) and HepG2 cells (hepatocellular carcinoma cell line). CTCF binding data for the non-myoblast cells were
mapped in IMR90 (lung ﬁbroblasts) by CTCF ChIP following by tiling array analysis (4) and in the other cell types by CTCF ChIP-seq. The single
CTCF site in this region is 4kb distal to DH10. High-resolution mapping of CTCF sites has not yet been done in myoblasts. Consvn, vertebrate
(17-way vertebrate alignment) or chicken/human conservation (http://genome.ucsc.edu/). (B) DH sites in the FAT1 and MTNR1A regions are cell
type-speciﬁc. Tracks and DH sites are labeled as in Panel A.
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In 4q35.2, there were 28 DH sites found in all six
myoblasts cell cultures (Supplementary Table S1). Five
were located in the 50-gene regions (within 2-kb
upstream through the ﬁrst intron; Supplementary Table
S1, boldface). These 50-region DH sites were more GC-
rich than the overall human genome, as is often found
for immediate 50-regions. Most of the other DH sites did
not share this property, but rather had GC percentages
similar to that of bulk human DNA (42% G+C).
We looked for primary and secondary structure motifs
that might be associated with the DH sites (including
DH272) that mapped within the gene deserts of 4q35.2
in myoblasts (Supplementary Table S1). This set of sites
was compared to four analogous sets of randomly chosen
sequences of similar G+C content and the length as for
the DH sites (35– 48% G+C; 338–1642 bp). No signiﬁ-
cant diﬀerences were seen between DH sites and random
control sequences in the frequencies of transcription factor
consensus motifs, the possible 4–6 k-mers (DSGene,
http://accelrys.com), the free energy of predicted second-
ary structures [Mfold web server, (42)] or the frequency
of potential intramolecular G quadruplexes [GQRS
Mapper, (43)].
One striking characteristic of DH sites in 4q35.2 was
that  20% of those observed in all six myoblast cultures
(Supplementary Table S1) overlapped a simple tandem
repeat [STR, (44)]. BLAST searches indicated, with one
exception, that the sequences of these DH-STR sites were
located at a single chromosomal position, as tandem
repeats in the reference genome. The exception, DH15,
was located 15-kb proximal to D4Z4 (Figure 2) and had
84–97% identity to sequences on chromosomes 3, 7 and
17. Four out of ﬁve of the most distal DH sites (80%)
observed in all six myoblast cultures overlapped an STR
while only one out of the remaining 23 DH sites (5%)
showed such overlap (Figure 2, grey circles). The STRs
overlapping DH sites in 4q35.2 had consensus lengths of
Figure 4. DH272 and DHFRG1 in the terminal 0.4Mb of 4q of myoblasts overlap DH sites and CTCF sites observed in other cell types. The average
data from three FSHD myoblast cell strains are shown; control myoblasts gave the same results except that the DH272 peak was missing or much
smaller (inset). Segmental duplications from the UCSC Genome Browser: orange, >99% similarity (mostly to 10q26.3) and grey, 90–98% similarity.
Grey dots, DH peaks that overlap STRs (see legend to Figure 2) the only peaks overlapping STRs and seen in all six myoblast cultures in this
subregion of 4q35.2 were DH13 and DH15. CTCF data are shown as in Figure 3. DUX4C (grey font) is a predicted gene. Only a few copies of
DUX4 within each D4Z4 3.3-kb unit are shown (see Figure 1). The inset displays the mapped DH sites in each of the six studied myoblast cultures in
the indicated subregion.
Nucleic Acids Research, 2009,Vol.37, No. 22 738727–142 nt and were tandemly repeated 3–59 times
(Supplementary Table S1). They are unlikely to be
artifacts because all DH sites in DNase-chip were
identiﬁed by determining enrichment of DNase treated
versus randomly sheared material from the same individ-
ual (25). DH15, located 15-kb proximal to D4Z4, was the
only DH site overlapping an STR that was also detected
in whole genome DNase-seq data from other cell types
(data not shown). However, such STR-containing DH
sites may be missed because DNase-seq experiments
ﬁlter sequence tags that map to more than four places in
the reference genome (hg18). Interestingly, the repeat
overlapping DH15 has only three tandem copies in the
reference genome.
At the 1-Mb terminus of 4q, there were seven DH sites
observed in three to ﬁve of the six myoblast cultures,
rather than in all six of them (Figure 4 and data not
shown). Only one of these did not overlap an STR,
namely, DH272. It is located 272-kb proximal to D4Z4,
outside the region of high homology between subtelomeric
4q and 10q. It was also beyond the region shown to be
deleted in rare FSHD families with no eﬀect on the
phenotype [Figures 1 and 4, (16)].
A DH site 272kb from D4Z4 and qRT-PCR analyses
in its vicinity
DH272 was observed preferentially in FSHD versus
control myoblast cell strains (Figure 4). In other cell
types examined by DNase-seq, this DH site was usually
found at least as a small peak (Figure 4 and data not
shown). Data on CTCF binding to this region were avail-
able from ChIP followed by next-generation sequencing
for K562, HepG2 and GM12878 lymphoblasts (V. Iyer
and B.-K. Lee, recently released data) or by tiling array
analysis for lung ﬁbroblasts (4). CTCF binding
overlapped DH272 (as well as DHFRG1) in all of these
cell types (Figure 4 and data not shown). Myoblasts
have not yet been analyzed for CTCF binding in this
region but most CTCF binding sites seem to be invariant
among diﬀerent human cell types (4). Sequence conserva-
tion among vertebrates was observed in the DH272 peak,
including at the consensus sequence CTCF site, and
Figure 5. Cell type-speciﬁc global patterns of DH sites along 4q35.2 even in gene deserts. The average data from three FSHD and three normal
control myoblast cultures are shown; green dots, unique-sequence DH sites observed in all six cultures; grey dots, DH sites overlapping STRs and
star, DH272. For the other cell types, colored dots indicate the DH peak combination that is most characteristic for a given cell type. The ﬁbroblast
tracks are from two skin ﬁbroblast cell strains (GM02185 and GM05879) and the lymphoblast tracks from two lymphoblastoid cell lines (GM19238
and GM19239). The most distal portion of 4q35.2 ( 0.1Mb in hg18) is not shown because its DH peaks were not reliable, as seen in large variations
from sample to sample that we attribute to the many sequences throughout the genome displaying >93% identity to this subregion.
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Figures S2 and S5; Figure 3A; and data not shown). In
a preliminary comparative genome hybridization, using
high-density tiling arrays to compare two FSHD
samples with one control sample, we found no copy
number variations in the region of DH272.
Because DH sites sometimes mark promoters of
unannotated transcripts, we searched for evidence of tran-
scription surrounding DH272, DH8, DH9 and DH10.
Amplicons for qRT-PCR were chosen on the basis of
sequence conservation, proximity to the DH site and
locations of predicted genes (Supplementary Figure S5).
We compared diﬀerent unique amplicons with similar
PCR eﬃciency (as determined on genomic DNA) by
qRT-PCR using cDNA synthesized by random-hexamer
priming. Several subregions in the vicinity of DH272
had signiﬁcantly higher levels of RNA than others
(Figure 6A). The more highly expressed amplicons were
located 3.0- or 17-kb distal or 2.0-kb proximal to the
center of DH272. This interval spans 19kb. It is inter-
rupted by amplicons that gave signiﬁcantly less RT-PCR
product (Figure 6A), possibly due to posttranscriptional
processing or the use of several transcription units.
The RNA levels for these three amplicons were  200- to
500-fold lower than that for the HPRT standard, a mod-
erately transcribed gene. Therefore, these RNA levels were
low but within the range of weakly expressed, but well-
documented, genes (45).
In control ﬁbroblast cell strains and lymphoblastoid cell
lines (two each), transcripts from the three most highly
expressed amplicons in the vicinity of DH272 were also
signiﬁcantly (P<0.05) more abundant than those of
neighboring amplicons (data not shown). No signiﬁcant
tissue-speciﬁc diﬀerences were seen among myoblasts,
ﬁbroblasts and lymphoblasts. No FSHD-speciﬁc dif-
ferences were observed when comparing RNA from four
FSHD patients and three normal controls (data not
shown).
DISCUSSION
FSHD is associated with short arrays of the macrosatellite
D4Z4 at subtelomeric 4q but not at subtelomeric 10q. It is
still uncertain why, despite the near identity of 4q and 10q
D4Z4 and much homology proximally and distally,
FSHD is a 4q-speciﬁc disease. This dominant disease is
caused by the reduction in size of a 4q D4Z4 array past a
near-threshold of  36kb (Figure 1). For example, con-
traction of a 40-kb array (with 12 3.3-kb repeat units) to
one of 30kb (with 9 3.3-kb repeat units) can result in the
disease. We proposed that FSHD involves pathogenic
long-range looping in cis of the centromere-proximal
end of D4Z4 chromatin with 4q-speciﬁc sequences at
4q35.2 that is enabled by changes in intra-array chromatin
looping dependent on the array size (20,46). The impor-
tance of pathogenic chromatin structure changes to this
disease is indicated by recent evidence for FSHD-speciﬁc
chromatin alterations in the D4Z4 array itself in FSHD
patient’s cells (47,48). In addition, the most proximal
D4Z4 repeat unit apparently has a more open structure
than the bulk of the array (20,48,49). Many experimental
studies of the molecular genetics of FSHD do not dupli-
cate the unusual chromatin environment of 4q35.2, which
is likely to be critical for this disease in view of its 4q
speciﬁcity. We used DNase-chip to examine 4q35.2 for
chromatin features suggestive of a distinctive higher
order structure. Given the lack of deﬁnitive ﬁndings
about cis eﬀects of short D4Z4 arrays at 4q35.2 on gene
expression (10–14,34,35), DNase-chip also served as an
annotation-neutral method of ﬁnding evidence for
undocumented genes that may be important to FSHD in
this gene-sparse 4-Mb region.
At 4q35.2, we found 28 DH sites detectable in all six
examined myoblast cultures from FSHD patients or
normal controls. As expected, most were located in the
proximal 1Mb of 4q35.2, the most gene-rich subregion.
Surprisingly, within the bifurcated 3.1-Mb gene desert at
4q35.2 (Figure 2), 12 DH sites were observed in all tested
myoblast cultures >100kb from the nearest gene. For
some of these DH sites, notably DH8, DH9 and DH10,
the distances to the closest genes active in myoblasts were
very large, >0.7Mb. Nonetheless, these sites may identify
Figure 6. Some sequences in 4q35.2 gene deserts near DH sites are
transcribed much more than others.(A) Amplicons around DH272
(Supplementary Figure S5) were compared for their average steady-
state RNA levels among six myoblast cell strains (pooled data for
FSHD and control cell strains, three each) as determined by qRT-
PCR. +, distal;  , proximal. P-values (t-test) are given for the compar-
ison of the indicated amplicon to the amplicon 12-kb proximal to
DH272. (B) qRT-PCR determinations were done on amplicons
located 0.2-kb proximal or distal to the midpoint of the indicated
DH site and on the amplicon located 17-kb distal to DH272.
P-values are for comparison of the amplicon 17-kb proximal to
DH272 to the others.
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(50–53). Alternatively, they might be associated with
unannotated genes or structural elements, such as
looping hubs (54). That DH8, 9 and 10 were observed in
myoblasts and ﬁbroblasts, both of mesodermal origin, but
not in cells of the lymphoid, myeloid and hepatic lineages,
suggests functionality.
In the D4Z4-proximal 1-Mb region, which is mostly
gene desert, we found nine DH sites present in at least
three of the six myoblast cell cultures. Only two of
these, namely, DHFRG1 (in the promoter of FRG1) and
DH272 (in the distal gene desert) did not overlap a DNA
repeat. The other seven overlapped tandem repeats of
short units (STRs). We also observed that DH sites
frequently overlap STRs also in the terminal 1Mb of
10q by DNase-chip analysis (unpublished data). While
the biological signiﬁcance of these DH-STRs remains to
be determined, there are precedents for shorter tandem
repeats inﬂuencing nucleosome positioning and excluding
nucleosomes (55,56). With respect to DHFRG1, the DH site
at the FRG1 promoter, one group reported overexpression
of FRG1 RNA in FSHD muscle (17) but several others
were unable to conﬁrm this (11–13). In this study, we
found no diﬀerence between control and FSHD myoblasts
in this DH site and no signiﬁcant diﬀerence in the amount
of RNA product. DH272, the unique DH site located
150kb proximal to FRG1, was observed preferentially in
FSHD versus control myoblast cultures. Preliminary
results from DNase-seq on three other control myoblast
cell strains also revealed little or no DH peak at the
position of DH272. We found nearby unannotated
transcripts (probably non-coding RNAs, Supplementary
Figure S5) that were not FSHD-speciﬁc in myoblasts.
However, further study is needed of both myotubes and
myoblasts to test the possibility of disease-linked expres-
sion of amplicons in the vicinity of DH272 and other DH
sites in the 4q35.2 gene desert.
Even DH sites in 4q35.2 that did not display FSHD-
related diﬀerences might be involved in pathogenic
chromatin looping interactions. DH sites could be identi-
cal in both normal and disease cells, but the 3D structure
(looping) and protein complexes that bind to them could
diﬀer between them. Given that DH sites can be
associated with loci at which chromatin looping occurs
(54), our results suggest subregions of 4q35.2 with the
potential for these chromatin interactions that should be
investigated. Our study points to the DH272 region as
particularly attractive for searching for FSHD-related
sequences because of the overlap of DH272 with a
CTCF sequence found in many cell types [Figure 4 and
(4)]. Moreover, the potential CTCF binding site identiﬁed
in this ChIP-positive region of lung ﬁbroblasts by Kim
et al. (4) matched the CTCF consensus sequence at 19
out of 20nt. CTCF is a sequence-speciﬁc DNA-binding
protein with diverse functions, including as an insulator
and organizer of chromatin looping (54,57). CTCF
might play a role in our proposed pathogenic looping of
4q35.2-speciﬁc sequences to a short pathogenic D4Z4
array because D4Z4 was recently shown to have a
CTCF-binding sequence (47). Some evidence was
presented for increased binding of CTCF to D4Z4 in
FSHD versus control myoblasts (47).
In addition to the revealing candidate DNA sequences
for FSHD involvement in gene deserts, our data indicate
that FAT1 transcription warrants further study of possible
diﬀerences in FSHD and control muscle cells beyond the
few studies involving expression microarrays (11,13).
FAT1 is the only annotated 4q35.2 gene with evidence
for complex tissue-speciﬁc expression and, in this study,
a muscle-speciﬁc pattern of DH sites. Many myoblast-
speciﬁc DH sites were found in and around this large
gene in both FSHD and control cell strains, suggesting
that this subregion contains active regulatory elements
associated with the muscle lineage. The cell type-speciﬁc
diﬀerences in chromatin that we observed are consistent
with tissue-speciﬁc production of multiple FAT1 RNA
and protein isoforms from predicted gene-internal pro-
moters and by alternative splicing (http://www.ncbi.nlm
.nih.gov/IEB/Research/Acembly/). FAT1, which contains
>25 exons, encodes a cadherin-type integral membrane
protein which is implicated in diverse developmental and
signaling pathways, including in vascular smooth muscle
remodeling (58).
It has been proposed that a short disease-linked
D4Z4 array at 4q35.2, but not at 10q26.3, triggers
abnormal transcription of DNA sequences within the
array itself in aﬀected FSHD muscle cells (34,35,39,59).
Overexpression of DUX4 RNA, derived from the 1.6-kb
gene inside each 3.3-kb D4Z4 repeat unit, was reported in
FSHD myotubes relative to control myotubes (35) but
truncated transcripts or transcripts from other portions
of the D4Z4 repeat unit are more prevalent than full-
length DUX4 transcripts (34). Currently, deﬁnitive
conclusions as to the relationship of D4Z4 transcription
and pathogenicity are precluded by low expression levels,
small numbers of samples, many cross-hybridizing
sequences and the variety of small transcripts (34). If
dysregulated expression of some D4Z4 sequence from
short arrays initiates abnormal gene expression in
FSHD, it remains to be explained why it is only short
4q arrays that cause the disease despite the  98%
identity between 4q and 10q D4Z4 (8) and homology
outside the arrays (Figure 1). In addition, exchanges
between the almost (but not completely) identical 4q and
10q D4Z4 arrays are rather frequent and can result in an
array with 4q-type repeat units replacing all the 10q units
(60). Nonetheless, short D4Z4 arrays cause disease only
when they reside on 4q (61). Therefore, polymorphisms
that were found to be associated with canonical 4q-type
D4Z4 units, but not canonical 10q-type D4Z4 units (8),
are unlikely to explain the 4q linkage of FSHD.
We propose that the chromosomal environment of
4q35.2 plays a key role in the 4q-speciﬁc nature of
FSHD, whether abnormal expression from 4q containing
a short D4Z4 array initiates from within or outside D4Z4.
Both at the DNA and the chromosome levels, 4q35.2 is
unusual. It has the lowest gene density in its terminal 3Mb
of any of the q arms. It is distal to a large bifurcated gene
desert punctuated centrally by a few genes that appear
to be critical in early embryogenesis. Like some other
genes (62), especially those important in the control of
7390 Nucleic Acids Research, 2009,Vol.37, No. 22development (63), these inter-desert genes may be ﬂanked
by gene deserts to help keep their expression tightly
restricted to certain stages in development. They might
be part of large blocks chromatin with distinguishing
epigenetic features. In CD4
+ cells, this gene desert
region has histone modiﬁcations [(5) and http://genome
.ucsc.edu] indicative of inactive euchromatin rather than
constitutive heterochromatin. This is consistent with our
previous immunocytochemical and DNA replication
analyses of FSHD and control myoblasts (64). However,
given the complexity of epigenetic modiﬁcation of
chromatin, there can be a variety of types of large distinc-
tive chromatin blocks within euchromatin (65).
One of the properties that distinguishes subtelomeric
4q (which can have pathogenic D4Z4 arrays) and 10q
(whose D4Z4 arrays are always phenotypically neutral)
is that only the 4q subtelomere (and not 10q or 4q) has
a strong association with the nuclear rim in FSHD and
control myoblasts and myotubes (66). A marker that was
0.22Mb from D4Z4 on 4q35.2 (close to DH272) showed a
signiﬁcantly closer association with the nuclear periphery
than did D4Z4. The unusual localization of subtelomeric
4q to the nuclear periphery might be necessary for patho-
genicity. This localization may result partly from its
uncommonly large region of inactive euchromatin
(67,68) in a distinctive conformation, as reﬂected in its
low concentration of DH sites. Our results emphasize
the underappreciated importance of considering the
regional chromatin context of D4Z4 in analysis of the
mechanism by which contraction of D4Z4 to a size of
<36kb can lead to disease (69).
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